{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:36:36Z","timestamp":1778711796444,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.03.102","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T17:26:35Z","timestamp":1303233995000},"page":"4210-4217","source":"Crossref","is-referenced-by-count":18,"title":["Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis"],"prefix":"10.1016","volume":"29","author":[{"given":"Dabin","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daxin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald S.","family":"Petralia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Muszynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell W.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Ming","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Xing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.03.102_bib0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/QCO.0b013e3283298e4e","article-title":"Virulence mechanisms of Moraxella in the pathogenesis of infection","volume":"22","author":"Perez Vidakovics","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00431-007-0461-8","article-title":"What is new in otitis media?","volume":"166","author":"Corbeel","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/599375","article-title":"Moraxella catarrhalis, a human respiratory tract pathogen","volume":"49","author":"Murphy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1164\/rccm.200412-1747OC","article-title":"Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response","volume":"172","author":"Murphy","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0025","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004;113:1451\u201365.","DOI":"10.1542\/peds.113.5.1451"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/CMR.15.1.125-144.2002","article-title":"Moraxella catarrhalis: from emerging to established pathogen","volume":"15","author":"Verduin","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2011.03.102_bib0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003495-198600313-00020","article-title":"Branhamella catarrhalis as an indirect pathogen","volume":"31","author":"Wardle","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/14760584.8.1.77","article-title":"Current progress with Moraxella catarrhalis antigens as vaccine candidates","volume":"8","author":"Mawas","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0045","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1586\/erv.09.28","article-title":"Vaccine development for Moraxella catarrhalis: rationale, approaches and challenges","volume":"8","author":"Murphy","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0050","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/IAI.64.6.1900-1905.1996","article-title":"Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization","volume":"64","author":"Chen","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0055","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/IAI.66.2.540-548.1998","article-title":"Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis","volume":"66","author":"Aebi","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1574-695X.1997.tb01012.x","article-title":"The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies","volume":"17","author":"Yang","year":"1997","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0065","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1128\/IAI.61.5.2003-2010.1993","article-title":"A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model","volume":"61","author":"Helminen","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0070","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1086\/314501","article-title":"Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model","volume":"178","author":"Murphy","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02116522","article-title":"Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection","volume":"14","author":"Rahman","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0080","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/IAI.59.9.3346-3349.1991","article-title":"Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains","volume":"59","author":"Fomsgaard","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0085","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1128\/JCM.28.2.182-187.1990","article-title":"Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens","volume":"28","author":"Vaneechoutte","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0008-6215(94)80040-5","article-title":"Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238)","volume":"257","author":"Edebrink","year":"1994","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0008-6215(94)00276-L","article-title":"Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C","volume":"266","author":"Edebrink","year":"1995","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0100","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1128\/IAI.69.3.1358-1363.2001","article-title":"Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis","volume":"69","author":"Hu","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0105","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1128\/IAI.66.5.1891-1897.1998","article-title":"Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis","volume":"66","author":"Gu","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0110","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1128\/IAI.73.5.2790-2796.2005","article-title":"Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis","volume":"73","author":"Yu","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0115","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1128\/IAI.01915-06","article-title":"Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis","volume":"75","author":"Yu","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0120","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1128\/IAI.70.11.5982-5989.2002","article-title":"Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine","volume":"70","author":"Jiao","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0008-6215(96)90132-9","article-title":"The structures of oligosaccharides isolated from the lipopolysaccharide of Moraxella catarrhalis serotype B, strain CCUG 3292","volume":"295","author":"Edebrink","year":"1996","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1432-1033.1994.tb18616.x","article-title":"Characterization of the lipopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide","volume":"220","author":"Masoud","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0135","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.carres.2006.07.009","article-title":"Identification of a novel glycosyltransferase involved in LOS biosynthesis of Moraxella catarrhalis","volume":"341","author":"Wilson","year":"2006","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0140","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1128\/IAI.68.9.5261-5268.2000","article-title":"Lipooligosaccharide P(k) (Galalpha1\u20134Galbeta1\u20134Glc) epitope of Moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum","volume":"68","author":"Zaleski","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0145","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1111\/j.1742-4658.2007.06060.x","article-title":"Role of different moieties from the lipooligosaccharide molecule in biological activities of the Moraxella catarrhalis outer membrane","volume":"274","author":"Peng","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0882-4010(90)90094-7","article-title":"Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens","volume":"8","author":"Campagnari","year":"1990","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0155","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0171-2985(11)80352-9","article-title":"Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS","volume":"187","author":"Mandrell","year":"1993","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1574-695X.1996.tb00127.x","article-title":"Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease","volume":"16","author":"Moran","year":"1996","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0165","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/IAI.73.11.7569-7577.2005","article-title":"Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate","volume":"73","author":"Peng","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0170","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1128\/IAI.01570-07","article-title":"Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination","volume":"76","author":"Yu","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0175","doi-asserted-by":"crossref","unstructured":"York WS, Darvill AG, McNeil M, Stevenson TT, Albersheim P. Isolation and characterization of plant cell walls and cell wall components. Methods Enzymol 1985;118:3\u201340.","DOI":"10.1016\/0076-6879(86)18062-1"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0008-6215(84)85242-8","article-title":"A simple and rapid method for the permethylation of carbohydrates","volume":"131","author":"Ciucanu","year":"1984","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0185","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/IAI.60.8.3201-3208.1992","article-title":"Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin","volume":"60","author":"Gupta","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0190","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/IAI.61.5.1873-1880.1993","article-title":"Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates","volume":"61","author":"Gu","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/168167a0","article-title":"A colorimetric method for the determination of sugars","volume":"168","author":"Dubois","year":"1951","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0205","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1128\/IAI.64.10.4047-4053.1996","article-title":"Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins","volume":"64","author":"Gu","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0003-2697(82)90673-X","article-title":"A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels","volume":"119","author":"Tsai","year":"1982","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0215","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1128\/IAI.00294-09","article-title":"The use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies","volume":"77","author":"Schwingel","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.102_bib0220","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1016\/j.vaccine.2005.06.011","article-title":"Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits","volume":"23","author":"Cox","year":"2005","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T11:23:05Z","timestamp":1592479385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11005056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":44,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11005056"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.102","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}